Cagrilintide + Semaglutide blend 10mg
$109.99Price
Cagrilintide + Semaglutide is a dual-peptide research blend combining a long-acting amylin analog with a GLP-1 receptor agonist. This formulation is utilized in research settings to study metabolic signaling, appetite-related pathways, and energy balance.
Semaglutide is a synthetic analog of the GLP-1 hormone, commonly evaluated for its role in glucose regulation and insulin response. Cagrilintide is an amylin analog studied for its effects on satiety signaling and gastric emptying. Together, these compounds are researched for their complementary interaction within metabolic models.
This blend is commonly evaluated in studies focused on nutrient intake, hormonal signaling, and metabolic function.
